Phosphodiesterase 4D isoform 7 (PDE4D7) (PDE4D7)

Phosphodiesterase 4D isoform 7 (PDE4D7) is a cAMP-specific enzyme belonging to the PDE4 family, which plays a pivotal role in regulating intracellular signaling by hydrolyzing the second messenger cyclic adenosine monophosphate (cAMP) [1]. As a 'long' isoform of the PDE4D gene, PDE4D7 contains the Upstream Conserved Regions 1 and 2 (UCR1 and UCR2), which are essential for its dimerization and complex regulatory control [2]. A critical regulatory feature of PDE4D7 is its phosphorylation at Serine 129 (S129) within the UCR1 domain by Protein Kinase A (PKA); this modification significantly increases the enzyme's catalytic activity, creating a negative feedback loop that terminates cAMP signaling [3, 5]. In clinical research, PDE4D7 has emerged as a significant biomarker in prostate cancer, where its downregulation is associated with an increased risk of disease progression and post-surgical recurrence [4]. While current PDE4 inhibitors like roflumilast and apremilast target the catalytic site shared across all PDE4 isoforms, the specific regulation of PDE4D7 via the S129 site represents a potential avenue for more precise therapeutic modulation of cAMP dynamics in specific disease states [1, 4]. [1] UniProt Consortium. "UniProtKB - Q08499 (PDE4D_HUMAN)." UniProt. [2] Houslay, M. D., & Adams, D. R. (2003). "PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization." Biochemical Journal. [3] MacKenzie, S. J., et al. (2002). "PKA phosphorylation of the cAMP-specific phosphodiesterase PDE4D3." British Journal of Pharmacology. [4] Böttcher, R., et al. (2015). "The PDE4D7 score: a novel biomarker for prostate cancer." British Journal of Cancer. [5] Sette, C., & Conti, M. (1996). "Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase." Journal of Biological Chemistry.

Other names

cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform 7PDE4D7Phosphodiesterase 4D7DPDE3HSPDE4D7

Inhibition of cAMP-specific phosphodiesterase 4 activity, leading to increased intracellular cAMP levels and subsequent modulation of downstream signaling pathways.